KIAA1524 antibody
Quick Overview for KIAA1524 antibody (ABIN7672974)
Target
See all KIAA1524 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- CIP2A antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- KIAA1524
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- KIAA1524
-
Alternative Name
- CIP2A
-
Background
-
Synonyms: Protein CIP2A|Cancerous inhibitor of PP2A|p90 autoantigen|CIP2A|KIAA1524
Background: Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
-
Molecular Weight
- 102 kDa
-
Gene ID
- 57650
-
UniProt
- Q8TCG1
Target
-